Bio-Techne

389 articles about Bio-Techne

• BIO-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT, PROTEIN SCIENCES SEGMENT

  12/21/2021

  Bio-Techne Corporation (NASDAQ: TECH) today announced William A. Geist has been appointed President, Protein Sciences Segment, effective January 3 , 2022. 

• BIO-TECHNE ANNOUNCES FUTURE WILSON WOLF PURCHASE AGREEMENT

  12/14/2021

  Bio-Techne Corporation today announced it has entered into an option agreement with Wilson Wolf Corporation.  

• Bio-Techne Announces Publication of Lateral Flow Technology Proof-of-Concept Data

  12/8/2021

  Bio-Techne Corporation (NASDAQ: TECH) today announced the publication of an important manuscript in the journal Scientific Reports, a Nature Research journal, showing proof-of-concept of its proprietary lateral flow technology.

• Bio-Techne To Present At Upcoming Investor Conferences

  11/22/2021

  Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at two upcoming investor conferences.

• Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference

  11/9/2021

  Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel , Executive Vice President and Chief Financial Officer, will present at the Stifel 2021 Virtual Healthcare Conference on Tuesday, November 16, 2021 at 10:00 a.m. EDT .

• Asuragen Launches New Kit to Enable Broader Coverage of Gene Variants Linked to Cystic Fibrosis

  11/8/2021

  Bio-Techne Corporation announced that Asuragen, Inc., a Bio-Techne brand, has launched a new kit to detect pathogenic variants in the CFTR gene.

• Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference

  11/4/2021

  Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel , Executive Vice President and Chief Financial Officer, will present virtually at the Credit Suisse 30th Annual Healthcare Conference on Tuesday, November 9, 2021 at 11:20 a.m. EST

• Bio-Techne Announces Commercial Availability Of GMP-Grade Proteins From Dedicated GMP Facility

  11/3/2021

  Bio-Techne Corporation announced the commercial availability of GMP-grade materials manufactured at its St. Paul, MN GMP manufacturing facility.

• Bio-Techne Releases First Quarter Fiscal 2022 Results

  11/2/2021

  Bio-Techne Corporation reported its financial results for the first quarter ended September 30, 2021.

• Bio-Techne Declares Dividend - Nov 02, 2021

  11/2/2021

  Bio-Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended September 30, 2021.

• Bio-Techne Announces ExoDx Prostate Test Data Publication in the Journal of Prostate Cancer and Prostatic Diseases

  10/13/2021

  Bio-Techne Corporation today announced that Exosome Diagnostics, a Bio-Techne brand, has published important clinical research in the journal Prostate Cancer and Prostatic Diseases , entitled Predicting high-grade prostate cancer at initial biopsy

• Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results

  10/11/2021

  Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday, November 2, 2021 , at 8:00 a.m. CDT to review first quarter 2022 financial results.

• Bio-Techne Launches ExCellerate™ iPSC Expansion Medium

  9/14/2021

  Bio-Techne Corporation Bio-Techne announced the launch of a new medium for the expansion and maintenance of induced pluripotent stem cells for use in both research and translational workflows.

• Bio-Techne And Carterra Initiate A Clinical Research Collaboration For COVID-19 Variant Analysis

  9/8/2021

  Bio-Techne, a leading supplier of high-quality and innovative tools for life science research, therapeutic manufacturing and clinical diagnostics and Carterra Inc., the world leader in high-throughput antibody screening and characterization, announced a clinical research collaboration studying COVID-19 variants.

• Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference

  9/2/2021

  Bio-Techne Corporation announced that Chuck Kummeth, President and Chief Executive Officer, will present at the 2021 Virtual Wells Fargo Healthcare Conference on Thursday, September 9, 2021 at 2:00 p.m. EDT.

• Bio-Techne Releases Fourth Quarter Fiscal 2021 Results

  8/5/2021

  Bio-Techne Corporation reported its financial results for the fourth quarter ended June 30, 2021.

• Bio-Techne Declares Dividend - Aug 05, 2021

  8/5/2021

  Bio-Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended June 30, 2021.

• Bio-Techne's RNAscope™ Technology Aids in the Retrospective Tissue Diagnosis of COVID-19 in cases with no previous testing for SARS-CoV-2

  8/4/2021

  Bio-Techne Corporation announced that scientists at the U.S. Centers for Disease Control and Prevention recently highlighted the importance of fixed tissue analysis for retrospective diagnosis of SARS-CoV-2 infection and characterization of viral strains, particularly for fatal cases in which no previous testing for SARS-CoV-2 was performed.

• Bio-Techne Announces 2021 Investor Day and Webcast

  8/3/2021

  Bio-Techne Corporation announced that management will host its 2021 Investor Day on Friday, September 10, 2021, starting at 9:00 a.m. EDT.

• Bio-Techne and PROGEN Introduce New Simple Plex AAV2 Immunoassay

  7/28/2021

  Bio-Techne Corporation and PROGEN announced the launch of the Simple Plex™ Adeno-Associated Virus viral titer assay for AAV2 total capsid quantification.